(19)
(11) EP 4 281 092 A1

(12)

(43) Date of publication:
29.11.2023 Bulletin 2023/48

(21) Application number: 22705461.6

(22) Date of filing: 21.01.2022
(51) International Patent Classification (IPC): 
A61K 35/745(2015.01)
A61K 31/733(2006.01)
A61P 1/00(2006.01)
A61K 35/747(2015.01)
A61K 38/40(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/745; A61K 35/747; A61K 38/40; A61K 45/06; A23L 33/135
 
C-Sets:
  1. A61K 38/40, A61K 2300/00;
  2. A61K 31/733, A61K 2300/00;
  3. A61K 35/747, A61K 2300/00;
  4. A61K 35/745, A61K 2300/00;

(86) International application number:
PCT/IB2022/050532
(87) International publication number:
WO 2022/157697 (28.07.2022 Gazette 2022/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 21.01.2021 IT 202100001067

(71) Applicant: Nutraceutical Technology Pharma Biotech S.r.l.
64039 Penna Sant'Andrea (TE) (IT)

(72) Inventors:
  • PAZIENZA, Valerio
    71013 San Giovanni Rotondo FG (IT)
  • MARINI, Patrizia
    64020 Castelnuovo Vomano, Castellato TE (IT)

(74) Representative: Zaccaro, Elisabetta et al
Notarbartolo & Gervasi S.p.A. Viale Achille Papa, 30
20149 Milano
20149 Milano (IT)

   


(54) A NUTRACEUTICAL COMPOSITION FOR USE AS AN ADJUVANT IN A CANCER THERAPY